Insider Trading & Executive Data
Start Free Trial
7 insider trades in the last year. Go beyond summary counts with transaction-level detail, compensation intelligence, and institutional ownership context.
TOMI Environmental Solutions (TOMZ) develops and sells hydrogen peroxide–based disinfection equipment, consumables and professional services built around its patented Binary Ionization Technology (BIT) and the SteraMist iHP platform. Revenue mixes capital equipment sales, recurring BIT Solution consumables and growing service/validation contracts (routine and emergency decontamination, IOQ/OQ/PQ), with target end markets in Life Sciences, Healthcare, Food Safety and broad Commercial applications. The company outsources manufacturing, retains IP and design control, and emphasizes recurring “razor/razor‑blade” consumable and service revenue to stabilize cash flow, but remains a small organization (≈20 employees) with material regulatory dependencies (EPA/FIFRA, FDA) and seasonal/long‑lead CES project timing. Recent financials show modest revenue growth ($7.74M in 2024) but widening losses (net loss $4.48M), compressed margins from inventory/receivable reserves, and tight liquidity (cash down to ~$665K in 2024 and ~$569K in mid‑2025).
Given TOMI’s size, industry and liquidity pressure, executive pay is likely tilted toward equity and performance‑linked awards with constrained cash salaries; management disclosed a 30% reduction in executive cash pay and other cost cuts to preserve cash. Performance metrics that will likely drive bonuses and equity vesting include recurring consumable sales and service revenue growth (margin‑rich), CES/SIS order closures and backlog conversion, gross margin improvement, and successful regulatory approvals or OEM partnerships. The company’s reliance on convertible debt and need for frequent capital raises means equity‑based compensation is used both to conserve cash and align executives with shareholder dilution outcomes; the spike in interest and financing costs (convertible notes, 12% programs noted in 2025) makes dilution and conversion price outcomes material to pay value. Low absolute R&D spend and a small headcount suggest executive incentives will prioritize commercial deployments and partner expansion over heavy product R&D milestones.
As a small, thinly traded industrials/chemicals company with visible event drivers, insider trades can move price and are often informative: material events include EPA registrations/List Q designations, large CES/SIS contract awards, OEM/distribution partnerships and financing rounds (convertible note issuances and conversions). Management and directors are subject to Section 16 reporting and short‑swing rules, and the company’s frequent financings and going‑concern disclosures increase the likelihood of blackout periods and reliance on 10b5‑1 plans; watch insider sales around announced financings or conversions and purchases during tight cash periods as potential confidence signals. Because material nonpublic information (e.g., regulatory approvals, large customer installs, bid wins) can be highly value‑moving, expect strict trading restrictions and clustered insider activity around public disclosures; low float amplifies the market impact of any insider buying or selling.